![Nenad Grmusa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nenad Grmusa is currently Chief Executive Officer & Director at DEM BioPharma, Inc. since 2022.
Formerly, Mr. Grmusa was an Outside Director at Chordia Therapeutics, Inc.
| Sociétés | Poste | Début |
|---|---|---|
DEM BioPharma, Inc.
 DEM BioPharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that manufactures cancer therapeutics | Directeur Général | 27/09/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| CHORDIA THERAPEUTICS INC. | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 2 |
|---|---|
Chordia Therapeutics, Inc.
 Chordia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures oncology drugs | Health Technology |
DEM BioPharma, Inc.
DEM BioPharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that manufactures cancer therapeutics | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
